Alivus Life Sciences Limited (ALIVUS)
Market Open
15 Oct, 10:00 AM
XNSE XNSE Primary ₹
1,340. 10
-7.9
-0.5861%
₹
130.3B Market Cap
- P/E Ratio
5% Div Yield
60,338 Volume
- Eps
₹ 1,348
Previous Close Want to track ALIVUS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alivus Life Sciences Limited (ALIVUS) Statistics
Valuation metrics
Market Cap 130.3B
Enterprise value 163.34B
Trailing P/E (ttm) 27
Forward P/E 18.26
PEG ratio 1.26
Price/Sales (ttm) 6.28
Price/Book (mrq) 4.89
Enterprise Value/Revenue 6.31
Enterprise Value/EBITDA 18.68
Overview
Shares outstanding 122.74M
Float 30.89M
Shares short -
% Held by insiders 0.76%
% Held by institutions 0.08%
Average volume (10 days) 122.42K
Average volume (90 days) 160.39K
Price summary
52-Week low 819
52-Week high 1,493.8
Beta -
50-Day moving average 1,376.74
200-Day moving average 1,179.37
Dividends and splits
Forward annual dividend rate 5
Forward annual dividend yield 0.0048%
Trailing annual dividend rate 5
Trailing annual dividend yield 0.0038%
5-Year annual dividend yield -
Payout ratio 0.1
Dividend Date 11 Sep 2026
Ex-Dividend Date 1 Sep 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.23%
Operating margin 0.29%
Operational effectiveness
Return on assets 0.15%
Return on equity 0.19%
Income Statement
Revenue (ttm) 26.12B
Revenue per share (ttm) 211.05
Quarterly revenue growth (yoy) 0.1%
Gross profit (ttm) 15.46B
EBITDA 8.36B
Net income to common (ttm) 5.64B
Diluted EPS (ttm) 49.13
Quarterly earnings growth (yoy) 0.15%
Balance Sheet
Total cash (mrq) 7.83B
Total cash per share (mrq) 63.75
Total debt (mrq) 567.71M
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 5.21%
Book value per share (mrq) 271.48
Cash Flow
Cash flow statement 5.65B
Levered free cash flow (LFCF) 2.09B
2026 © Marketlog. All Rights Reserved.
